Detalhe da pesquisa
1.
Efficacy and safety of the dual GIP and GLP-1 receptor agonist tirzepatide for weight loss: a meta-analysis of randomized controlled trials.
Int J Obes (Lond)
; 47(10): 883-892, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37460681